PREDIERI, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 31.479
EU - Europa 28.705
AS - Asia 18.386
SA - Sud America 2.366
AF - Africa 490
OC - Oceania 182
Continente sconosciuto - Info sul continente non disponibili 21
Totale 81.629
Nazione #
US - Stati Uniti d'America 30.752
IT - Italia 12.650
SG - Singapore 6.283
GB - Regno Unito 4.957
CN - Cina 4.679
SE - Svezia 3.483
HK - Hong Kong 2.283
DE - Germania 1.773
BR - Brasile 1.706
VN - Vietnam 1.693
FI - Finlandia 1.239
FR - Francia 1.010
UA - Ucraina 800
RU - Federazione Russa 715
TR - Turchia 580
KR - Corea 574
IN - India 545
NL - Olanda 386
CA - Canada 360
ID - Indonesia 310
BG - Bulgaria 307
JP - Giappone 222
AR - Argentina 204
MX - Messico 203
BD - Bangladesh 197
ES - Italia 192
IE - Irlanda 192
CH - Svizzera 154
PL - Polonia 150
ZA - Sudafrica 146
AU - Australia 144
IQ - Iraq 142
PK - Pakistan 142
EC - Ecuador 114
IR - Iran 97
BE - Belgio 90
EG - Egitto 90
LT - Lituania 89
AT - Austria 82
MY - Malesia 80
DK - Danimarca 78
VE - Venezuela 77
BZ - Belize 74
CO - Colombia 71
AE - Emirati Arabi Uniti 70
CL - Cile 64
CZ - Repubblica Ceca 55
PH - Filippine 54
TH - Thailandia 53
PT - Portogallo 47
UZ - Uzbekistan 46
MA - Marocco 45
PE - Perù 45
RO - Romania 45
SA - Arabia Saudita 45
PY - Paraguay 41
GR - Grecia 37
NZ - Nuova Zelanda 37
TW - Taiwan 37
JO - Giordania 36
DZ - Algeria 35
NP - Nepal 35
TN - Tunisia 35
KE - Kenya 32
IL - Israele 30
ET - Etiopia 26
AZ - Azerbaigian 23
RS - Serbia 22
BO - Bolivia 21
HU - Ungheria 21
DO - Repubblica Dominicana 19
AL - Albania 18
KZ - Kazakistan 17
NG - Nigeria 17
CR - Costa Rica 15
NO - Norvegia 15
UG - Uganda 15
UY - Uruguay 15
EU - Europa 13
PA - Panama 13
SM - San Marino 13
KW - Kuwait 11
OM - Oman 11
CY - Cipro 10
EE - Estonia 10
SI - Slovenia 10
LB - Libano 9
SK - Slovacchia (Repubblica Slovacca) 9
AM - Armenia 8
GE - Georgia 8
LV - Lettonia 8
MT - Malta 8
PS - Palestinian Territory 8
HN - Honduras 7
HR - Croazia 7
LK - Sri Lanka 7
MK - Macedonia 7
BH - Bahrain 6
BY - Bielorussia 6
GY - Guiana 6
Totale 81.478
Città #
Singapore 4.246
Southend 3.321
Santa Clara 3.205
Ashburn 2.808
Fairfield 2.255
Hong Kong 2.204
Stockholm 1.810
Chandler 1.624
Woodbridge 1.600
Houston 1.563
San Jose 1.508
Hefei 1.418
Jacksonville 1.365
Dearborn 1.130
Helsinki 939
Rome 931
Milan 919
Nyköping 888
Ann Arbor 859
London 847
Seattle 844
Beijing 819
Wilmington 814
Cambridge 686
Seoul 536
Ho Chi Minh City 522
The Dalles 517
Los Angeles 482
New York 471
Council Bluffs 441
Hanoi 384
Naples 381
Munich 377
Bologna 347
Princeton 325
Chicago 305
Lauterbourg 294
Sofia 287
Modena 272
Eugene 253
San Diego 253
Palermo 248
Turin 227
Jakarta 220
Shanghai 218
Redwood City 217
Moscow 214
Buffalo 210
Izmir 208
Frankfurt am Main 195
Bremen 187
Orem 186
Bari 169
São Paulo 165
Dublin 151
Florence 146
Dallas 143
Catania 140
Tokyo 132
Padova 121
Verona 111
Boardman 109
Columbus 107
Parma 104
Fremont 98
Chennai 96
Des Moines 95
Salt Lake City 95
Johannesburg 94
Warsaw 94
Toronto 93
Da Nang 84
Las Vegas 81
Phoenix 81
Montreal 79
Albuquerque 78
Guangzhou 78
Amsterdam 75
Genoa 74
Tampa 74
Belize City 73
Haiphong 71
Nuremberg 71
Falls Church 70
Brescia 68
Mumbai 62
Dong Ket 61
Mexico City 61
Nanjing 61
Rio de Janeiro 61
Paris 60
Pescara 60
Turku 59
Atlanta 56
Denver 55
Poplar 55
Redondo Beach 55
Brooklyn 53
Cairo 53
Kent 52
Totale 51.564
Nome #
CASO CLINICO: SINDROME DA MICRODELEZIONE 16p11.2 PROSSIMALE 4.662
"Balanced translocation" T(3;11)(P21;Q13) in a lipoma from a girl with suspected MEN 1 Syndrome. 1.993
Diabete tipo 2 e obesità pediatrica: rassegna a cura dei Gruppi di Studio Obesità Infantile e Diabete della Società Italiana di Endocrinologia e Diabetologia Pediatrica 1.161
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.148
I DISORDINI DELLO SVILUPPO SESSUALE E LE MALFORMAZIONI DELL’APPARATO GENITALE 898
Si può “Valere” di più: un progetto italiano studia i disturbi alimentari negli adolescenti con diabete tipo 1. Dati preliminari 779
Gestione del Covid-19 in età pediatrica: documento di consenso 754
Effetti degli interferenti endocrini su crescita e sviluppo puberale 680
Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes 638
BODY EMOTIONAL MAP: STRUMENTO INNOVATIVO ED UTILE PER MIGLIORARE L’ADATTAMENTO DEI GENITORI ALLA DIAGNOSI DI DIABETE DI TIPO 1 DEL LORO BAMBINO 617
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 522
Lactobacillus reuteri oral administration improves periodontal disease in children and adolescents with type 1 diabetes 475
COMPLICANZE MACROVASCOLARI E MORTALITÀ NEL DIABETE TIPO 1 456
Oral Administration of Lactobacillus Reuteri Improves Periodontal Disease in Children and Adolescents with Type 1 Diabetes 438
MALATTIA PARODONTALE IN BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1: EFFICACIA DELLA SOMMINISTRAZIONE ORALE DI LACTOBACILLUS REUTERI 412
High basal serum allopregnanolone levels in overweight girls 401
Hypospadias: clinical approach, surgical technique and outcome. Twenty years’ experience of a single centre 399
Accuracy of SenseWear Pro2 armband to predict resting energy expenditure in childhood obesity. 381
The Effect of GnRH-Analogue Therapy on the Quality of Life of Patients with Central Precocious Puberty and their Families 378
Endothelial and heart dysfunction in children and adolescents with type 1 diabetes 376
Diabetic ketoacidosis at the onset of disease during a national awareness campaign: a 2-year observational study in children aged 0-18 years 374
Alti livelli di anticorpi antitransglutaminasi predicono la malattia celiaca in bambini e adolescenti italiani con diabete mellito tipo 1. 372
Effects of Exercise in Children and Adolescent with Type 1 Diabetes Mellitus 369
Long-term effects on growth, development, and metabolism of ALL treatment in childhood 369
CONSEGUENZE METABOLICHE A BREVE E LUNGO TERMINE IN PAZIENTI CON PUBERTÀ PRECOCE CENTRALE TRATTATI CON GNRHA IN ETÀ EVOLUTIVA: STUDIO LONGITUDINALE MONOCENTRICO 367
Childhood obesity and environmental pollutants: a dual relationship 365
Anti-pituitary antibodies in children with newly diagnosed celiac disease: a novel finding contributing to linear-growth impairment. 363
Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study 363
IMPATTO DELLA TERAPIA CON ANALOGO DEL GNRH SULLA QUALITÀ DELLA VITA DEI PAZIENTI CON CPP E DELLE LORO FAMIGLIE 361
THE IMPACT OF SENSOR-AUGMENTED INSULIN PUMP (SAP) THERAPY ON QUALITY OF LIFE (QOL) IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES (T1D) AND THEIR PARENTS 359
IPERTENSIONE IN BAMBINI ED ADOLESCENTI AFFETTI DA DIABETE DI TIPO 1: ALTA PREVALENZA IDENTIFICATA TRAMITE L’UTILIZZO DEL MONITORAGGIO PRESSORIO AMBULATORIALE 357
DETERMINANTI DELLA HEALTH RELATED QUALITY OF LIFE (HRQOL) IN ADOLESCENTI OBESI ITALIANI 356
Longitudinal evaluation of endothelial function in children and adolescents with type 1 diabetes mellitus: a long term follow up study. 355
Age-period-cohort analysis of 1990-2003 incidence time trends of childhood diabetes in Italy: The RIDI study 352
Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting 350
Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: An Italian cohort study 349
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 347
Low serum allopregnanolone levels in girls with precocious pubarche 342
Dolore addominale acuto nelle adolescenti: le principali patologie di natura ginecologica 334
L’ipercolesterolemia familiare: terapia farmacologica 329
Approaches to dyslipidemia treatment in children and adolescents 328
Effect of Weight Loss on Markers of Inflammation and Endothelial Function in Childhood Obesity 327
Brain-derived neurotrophic factor and epilepsy: a systematic review 326
Abdominal adiposity and cardiovascular risk factors in adolescents with type 1 diabetes 324
VALUTAZIONE AUXO-ENDOCRINOLOGICA DEI PAZIENTI AFFETTI DA SICKLE CELL DISEASE (SCD): DATI PRELIMINARI 308
Safety outcomes during pediatric GH therapy: final results from the prospective GeNeSIS observational program 304
A 1-year long-term study on efficacy and safety of degludec in children and adolescents with type 1 diabetes 303
QUALITÀ DI VITA E CONTROLLO METABOLICO NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 E NEI LORO GENITORI PRIMA E DOPO IL LOCKDOWN PER COVID-19. 298
A Multicenter Retrospective Survey regarding Diabetic Ketoacidosis Management in Italian Children with Type 1 Diabetes 296
EFFICACIA E SICUREZZA DI DEGLUDEC NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 296
COVID-19 and Type 1 Diabetes: Concerns and Challenges 295
Unusual presentation of Rosai-Dorfman disease in a 14-month-old Italian child: a case report and review of the literature 294
Growth hormone impaired secretion and antipituitary antibodies in patients with coeliac disease and poor catch-up growth after a long gluten-free diet period: a causal association? 292
Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndrome. 291
Efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes 288
High prevalence of hypertension in children and adolescents with type 1 diabetes identified through the 24 hours ambulatory blood pressure monitoring 287
Basi genetiche ed aspetti terapeutici delle ipercolesterolemie familiari 285
Plasma brain-derived neurotrophic factor concentrations in children and adolescents. 283
Endocrine and Metabolic Complications in Children and Adolescents with Sickle Cell Disease: An Italian Cohort Study 283
Obesity in pediatric age: The analysis of genomic rearrangements 280
Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: A review 278
SHORT STATURE HOMEOBOX-CONTAINING GENE AND IDIOPATHIC SHORT STATURE 277
Thyroid function in patients with Prader-Willi syndrome: an Italian multicenter study of 339 patients 277
Weekend-Based Parent-Group Intervention to Reduce Stress in Parents of Children and Adolescents with Type 1 Diabetes: A Pilot Study 276
Endocrine immune-related adverse effects of immune-checkpoint inhibitors 275
Relationship between body mass index and insulin measured during oral glucose tolerance testing in severely obese children and adolescents 275
Health-Related Quality of Life and Metabolic Control in Immigrant and Italian Children and Adolescents with Type 1 Diabetes and in their Parents 271
Longitudinal study of the endothelial function in children and adolescents affected by type 1 diabetes mellitus 270
Endocrine Disrupting Chemicals and Type 1 Diabetes 269
Hypercholesterolemia in Childhood 266
Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic 266
Lipide profile, antioxidant factors and endothelial function in children and adolescent with type 1 diabetes mellitus 265
Complex disease phenotype revealed by GH deficiency associated with a novel and unusual defect in the GH-1 gene. 265
High levels of serum perfluorinated compounds in children with endocrine autoimmune disease. 263
A new device for measuring resting energy expenditure in severely obese children and adolescents with and without non-alcoholic fatty liver disease. 263
Tracheobronchial anomalies in chromosome 22q11.2 microdeletion 262
Low-density lipoprotein oxidizability in children with chronic renal failure 261
MicroRNAs change and target key regulatory genes involved in longitudinal growth in patients with idiopathic isolated growth hormone deficiency (IGHD) on growth hormone (GH) treatment 261
Can inflammatory marker levels help in detecting early complications of childhood obesity? 260
Natural history of congenital hypothyroidism in the last two decades: what is changing? Experience of a single tertiary Italian paediatric centre 260
Thirty-year persistence of obesity after presentation to a pediatric obesity clinic. 259
Evaluation and management of hyperlipidemia in children and adolescents. 258
Insulin pump failures in Italian children with Type 1 diabetes: retrospective 1-year cohort study 258
Efficacy and Safety of Degludec in Children and Adolescents with Type 1 Diabetes 257
Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry 256
Prevalence and risk factors for microalbuminuria in children and adolescents with type 1 diabetes: long-term experience of a single centre 255
Allopregnanolone Levels Decrease after Gonadotropin Releasing Hormone Analogue Stimulation Test in Girls with Central Precocious Puberty. 255
Endocrine-disrupting chemicals and their effects during female puberty: A review of current evidence 255
Confocal microscopy: Improving our understanding of nevogenesis 253
High g-glutamyl-transferase fractions as new markers to identify non-alcoholic fatty liver disease in childhood obesity 253
Rhabdomyoma of a rare type in a child: Case report and literature review 252
Endothelial function in adolescents with type 1 diabetes mellitus (TIDM) [Funzione endoteliale in adolescenti con diabete di tipo 1], 252
Organization and regional distribution of centers for the management of children and adolescents with diabetes in Italy 252
Adrenal Hypoplasia Seemingly First as a Primary Hypoaldosteronism 252
Markers of Inflammation and Endothelial Dysfunction in Young Survivors from Acute Lymphoblastic Leukemia 252
Novel insights on the treatment of hypercholesterolemia 251
Impaired GH Secretion in Patients with SHOX Deficiency and Efficacy of Recombinant Human GH Therapy. 250
Recommendations for self-monitoring in pediatric diabetes: a consensus statement by the ISPED. 250
Elevata incidenza di Diabete tipo 1 tra i bambini di famiglie migranti provenienti dal Nord Africa nella regione Emilia Romagna. 250
Efficacy of telemedicine in patients with type 1 diabetes over the second year by the COVID-19 pandemic spread 249
Totale 41.118
Categoria #
all - tutte 262.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 262.115


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.648 0 0 0 0 0 0 0 0 0 694 549 405
2021/20226.054 208 655 466 561 343 392 309 405 625 466 933 691
2022/20237.655 723 631 466 588 825 923 366 760 927 382 600 464
2023/20247.290 389 447 495 698 983 694 585 870 416 427 571 715
2024/202515.136 572 469 440 1.066 2.521 2.130 1.193 874 1.973 920 1.335 1.643
2025/202624.656 1.631 972 2.031 2.832 3.901 2.037 3.590 1.304 3.980 2.378 0 0
Totale 82.454